Stanley C. Erck
2017
In 2017, Stanley C. Erck earned a total compensation of $2.8M as President, CEO and Interim CFO at Novavax, a 29% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $383,760 |
|---|---|
| Option Awards | $1,753,125 |
| Salary | $624,000 |
| Other | $10,800 |
| Total | $2,771,685 |
Erck received $1.8M in option awards, accounting for 63% of the total pay in 2017.
Erck also received $383.8K in non-equity incentive plan, $624K in salary and $10.8K in other compensation.
Rankings
In 2017, Stanley C. Erck's compensation ranked 3,959th out of 14,666 executives tracked by ExecPay. In other words, Erck earned more than 73.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,959 out of 14,666 | 73rd |
Division Manufacturing | 1,386 out of 5,770 | 76th |
Major group Chemicals And Allied Products | 398 out of 2,074 | 81st |
Industry group Drugs | 307 out of 1,730 | 82nd |
Industry Biological Products, Except Diagnostic Substances | 56 out of 316 | 82nd |
Source: SEC filing on April 30, 2018.
Erck's colleagues
We found four more compensation records of executives who worked with Stanley C. Erck at Novavax in 2017.